C

Cannabis Poland SA
WSE:CBD

Watchlist Manager
Cannabis Poland SA
WSE:CBD
Watchlist
Price: 0.301 PLN -5.94%
Market Cap: 14.8m PLN
Have any thoughts about
Cannabis Poland SA?
Write Note

Cannabis Poland SA
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cannabis Poland SA
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
C
Cannabis Poland SA
WSE:CBD
PP&E Net
zł180.2k
CAGR 3-Years
N/A
CAGR 5-Years
78%
CAGR 10-Years
N/A
M
Molecure SA
WSE:MOC
PP&E Net
zł10.6m
CAGR 3-Years
10%
CAGR 5-Years
32%
CAGR 10-Years
N/A
C
Celon Pharma SA
WSE:CLN
PP&E Net
zł323.8m
CAGR 3-Years
-1%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Cannabis Poland SA
Glance View

Market Cap
14.8m PLN
Industry
Pharmaceuticals

Cannabis Poland SA engages in the production and distribution of cannabinoid vaporization equipment and oils. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2013-04-09. The firm focuses on operating in the field of production and sale of pharmaceutical and medical products, with the main focus on vaporization products containing cannabinoids manufactured from cannabis. The firm also expands its activity to include other products than pharmaceuticals, such as cosmetics, oils containing cannabinoids for human and animals and photovoltaic cells. The firm is engaged in research and development of a Cannabidiol (CBD)/ Tetrahydrocannabinol-based (THC-based) pharmaceutical for use in the treatment of seizures associated with drug-resistant epilepsy.

CBD Intrinsic Value
0.016 PLN
Overvaluation 95%
Intrinsic Value
Price
C

See Also

What is Cannabis Poland SA's PP&E Net?
PP&E Net
180.2k PLN

Based on the financial report for Dec 31, 2023, Cannabis Poland SA's PP&E Net amounts to 180.2k PLN.

What is Cannabis Poland SA's PP&E Net growth rate?
PP&E Net CAGR 5Y
78%

Back to Top